LONDON, Ontario, May 10, 2022 (GLOBE NEWSWIRE) -- BLES Biochemicals Inc. is an established global player in providing innovative solutions for treating neonatal respiratory distress syndrome (NRDS ...

Scientists at the University of Southampton's Zepler Institute for Photonics and Nanoelectronics are developing a rapid bedside test for diagnosing neonatal Respiratory Distress Syndrome (nRDS) in ...

BLEScath™ Intratracheal catheter for less invasive administration of pulmonary surfactant NRDS is a challenge mitigated by integrated scientific solutions. LONDON, Ontario, May 10, 2022 (GLOBE ...